← Open Payments lookup

JENNA LASKOSKI: Open Payments

NPI 1316609209 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$422 in 19 payments from 10 companies in 2025. Trend: 2023 $91 · 2024 $1,092 · 2025 $422

Food & beverage: $422
CompanyPaymentsAmount
Gilead Sciences, Inc.6$119
Takeda Pharmaceuticals U.S.A., Inc.2$57
PFIZER INC.2$52
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$34
ABBVIE INC.2$32
Mauna Kea Technologies, Inc.1$29
Aimmune Therapeutics, Inc.1$28
Boston Scientific Corporation1$27
Janssen Biotech, Inc.1$26
Lilly USA, LLC1$18

Products named: ENTYVIO, LINZESS, ZENPEP, General - Pain Management, XELJANZ, TREMFYA, VELSIPITY, RELISTOR.

Industry payments across AZ — which companies pay providers there.